Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina
- PMID: 21045809
- PMCID: PMC3034844
- DOI: 10.1038/mt.2010.234
Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina
Abstract
Vectors based on adeno-associated virus serotype 2 (AAV2) have been used extensively in many gene-delivery applications, including several successful clinical trials for one type of Leber congenital amaurosis in the retina. Many studies have focused on improving AAV2 transduction efficiency and cellular specificity by genetically engineering its capsid. We have previously shown that vectors-containing single-point mutations of capsid surface tyrosines in serotypes AAV2, AAV8, and AAV9 displayed significantly increased transduction efficiency in the retina compared with their wild-type counterparts. In the present study, we evaluated the transduction characteristics of AAV2 vectors containing combinations of multiple tyrosine to phenylalanine mutations in seven highly conserved surface-exposed capsid tyrosine residues following subretinal or intravitreal delivery in adult mice. The multiply mutated vectors exhibited different in vivo transduction properties, with some having a unique ability of transgene expression in all retinal layers. Such novel vectors may be useful in developing valuable new therapeutic strategies for the treatment of many genetic diseases.
Figures
Similar articles
-
High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.Mol Ther. 2009 Mar;17(3):463-71. doi: 10.1038/mt.2008.269. Epub 2008 Dec 16. Mol Ther. 2009. PMID: 19066593 Free PMC article.
-
Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.J Virol. 2016 Mar 28;90(8):4215-4231. doi: 10.1128/JVI.00200-16. Print 2016 Apr. J Virol. 2016. PMID: 26865709 Free PMC article.
-
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach.Gene Ther. 2014 Jan;21(1):96-105. doi: 10.1038/gt.2013.64. Epub 2013 Nov 14. Gene Ther. 2014. PMID: 24225638 Free PMC article.
-
Single tyrosine mutation in AAV8 vector capsid enhances gene lung delivery and does not alter lung morphofunction in mice.Cell Physiol Biochem. 2014;34(3):681-90. doi: 10.1159/000363033. Epub 2014 Aug 18. Cell Physiol Biochem. 2014. PMID: 25171090
-
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.Hum Mol Genet. 2001 Dec 15;10(26):3075-81. doi: 10.1093/hmg/10.26.3075. Hum Mol Genet. 2001. PMID: 11751689
Cited by
-
Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss.Mol Ther Methods Clin Dev. 2021 Mar 10;21:209-236. doi: 10.1016/j.omtm.2021.03.005. eCollection 2021 Jun 11. Mol Ther Methods Clin Dev. 2021. PMID: 33850952 Free PMC article. Review.
-
Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death.Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4045-50. doi: 10.1073/pnas.1211284110. Epub 2013 Feb 19. Proc Natl Acad Sci U S A. 2013. PMID: 23431148 Free PMC article.
-
Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency.Mol Ther Methods Clin Dev. 2024 Jan 17;32(1):101187. doi: 10.1016/j.omtm.2024.101187. eCollection 2024 Mar 14. Mol Ther Methods Clin Dev. 2024. PMID: 38327809 Free PMC article.
-
Single residue AAV capsid mutation improves transduction of photoreceptors in the Abca4-/- mouse and bipolar cells in the rd1 mouse and human retina ex vivo.Gene Ther. 2016 Nov;23(11):767-774. doi: 10.1038/gt.2016.54. Epub 2016 Jul 14. Gene Ther. 2016. PMID: 27416076 Free PMC article.
-
The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease.Int J Mol Sci. 2021 Oct 26;22(21):11542. doi: 10.3390/ijms222111542. Int J Mol Sci. 2021. PMID: 34768969 Free PMC article. Review.
References
-
- Mueller C., and, Flotte TR. Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther. 2008;15:858–863. - PubMed
-
- Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231–2239. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- EY08571/EY/NEI NIH HHS/United States
- HL59412/HL/NHLBI NIH HHS/United States
- R01 EY000667/EY/NEI NIH HHS/United States
- P01 NS036302/NS/NINDS NIH HHS/United States
- EY018335/EY/NEI NIH HHS/United States
- NS36302/NS/NINDS NIH HHS/United States
- R01 EY018335/EY/NEI NIH HHS/United States
- EY11123/EY/NEI NIH HHS/United States
- EY0667/EY/NEI NIH HHS/United States
- U10 EY013729/EY/NEI NIH HHS/United States
- P30 EY008571/EY/NEI NIH HHS/United States
- P01 HL059412/HL/NHLBI NIH HHS/United States
- R01 EY011123/EY/NEI NIH HHS/United States
- P30 EY021721/EY/NEI NIH HHS/United States
- EY07132/EY/NEI NIH HHS/United States
- EY13729/EY/NEI NIH HHS/United States
- R56 EY000667/EY/NEI NIH HHS/United States
- EY11087/EY/NEI NIH HHS/United States
- P50 HL059412/HL/NHLBI NIH HHS/United States
- R01 EY011087/EY/NEI NIH HHS/United States
- T32 EY007132/EY/NEI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
